Your browser doesn't support javascript.
loading
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
Stefanetti, Giuseppe; Hu, Qi-Ying; Usera, Aimee; Robinson, Zack; Allan, Martin; Singh, Alok; Imase, Hidetomo; Cobb, Jennifer; Zhai, Huili; Quinn, Douglas; Lei, Ming; Saul, Allan; Adamo, Roberto; MacLennan, Calman A; Micoli, Francesca.
Afiliación
  • Stefanetti G; Sclavo Behring Vaccines Institute For Global Health S.r.l., A GSK Company, Via Fiorentina 1, 53100 Siena (Italy).
  • Hu QY; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA). qiying.hu@novartis.com.
  • Usera A; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Robinson Z; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Allan M; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Singh A; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Imase H; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Cobb J; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Zhai H; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Quinn D; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Lei M; Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139 (USA).
  • Saul A; Sclavo Behring Vaccines Institute For Global Health S.r.l., A GSK Company, Via Fiorentina 1, 53100 Siena (Italy).
  • Adamo R; GSK, Via Fiorentina 1, 53100 Siena (Italy).
  • MacLennan CA; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ (UK).
  • Micoli F; Sclavo Behring Vaccines Institute For Global Health S.r.l., A GSK Company, Via Fiorentina 1, 53100 Siena (Italy). francesca.x.micoli@gsk.com.
Angew Chem Int Ed Engl ; 54(45): 13198-203, 2015 Nov 02.
Article en En | MEDLINE | ID: mdl-26350581
ABSTRACT
A series of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O-antigen to different amino acids of CRM197 protein carrier. In particular, two novel methods for site-selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of a disulfide bond and pH-controlled transglutaminase-catalyzed modification of lysine, respectively. Importantly, conjugation at the C186-201 bond resulted in significantly higher anti O-antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing a larger number of saccharides. This study demonstrates that the conjugation site plays a role in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Salmonella typhimurium / Glicoconjugados / Antígenos O / Vacunas contra la Salmonella Límite: Animals Idioma: En Revista: Angew Chem Int Ed Engl Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Salmonella typhimurium / Glicoconjugados / Antígenos O / Vacunas contra la Salmonella Límite: Animals Idioma: En Revista: Angew Chem Int Ed Engl Año: 2015 Tipo del documento: Article